A detailed history of Wedmont Private Capital transactions in Pfizer Inc stock. As of the latest transaction made, Wedmont Private Capital holds 37,473 shares of PFE stock, worth $958,184. This represents 0.06% of its overall portfolio holdings.

Number of Shares
37,473
Previous 35,479 5.62%
Holding current value
$958,184
Previous $992,000 9.27%
% of portfolio
0.06%
Previous 0.06%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$27.7 - $31.39 $55,233 - $62,591
1,994 Added 5.62%
37,473 $1.08 Million
Q2 2024

Jul 15, 2024

BUY
$25.26 - $29.6 $137,288 - $160,876
5,435 Added 18.09%
35,479 $992,000
Q1 2024

Apr 10, 2024

SELL
$25.89 - $29.73 $88,077 - $101,141
-3,402 Reduced 10.17%
30,044 $833,000
Q4 2023

Jan 09, 2024

BUY
$26.13 - $33.94 $5,278 - $6,855
202 Added 0.61%
33,446 $962,000
Q3 2023

Oct 10, 2023

BUY
$32.09 - $37.51 $315,669 - $368,985
9,837 Added 42.03%
33,244 $1.1 Million
Q2 2023

Jul 17, 2023

SELL
$36.12 - $41.79 $183,814 - $212,669
-5,089 Reduced 17.86%
23,407 $858,000
Q1 2023

Apr 11, 2023

SELL
$39.39 - $51.28 $332,372 - $432,700
-8,438 Reduced 22.85%
28,496 $1.16 Million
Q4 2022

Jan 09, 2023

BUY
$41.75 - $54.5 $483,256 - $630,837
11,575 Added 45.64%
36,934 $0
Q3 2022

Oct 03, 2022

SELL
$43.76 - $53.42 $48,486 - $59,189
-1,108 Reduced 4.19%
25,359 $1.11 Million
Q2 2022

Jul 11, 2022

BUY
$46.53 - $55.17 $441,616 - $523,618
9,491 Added 55.91%
26,467 $1.39 Million
Q1 2022

Apr 05, 2022

BUY
$45.75 - $56.69 $151,661 - $187,927
3,315 Added 24.27%
16,976 $865,000
Q4 2021

Jan 14, 2022

BUY
$41.32 - $61.25 $564,472 - $836,736
13,661 New
13,661 $759,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Wedmont Private Capital Portfolio

Follow Wedmont Private Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedmont Private Capital, based on Form 13F filings with the SEC.

News

Stay updated on Wedmont Private Capital with notifications on news.